Skip to main content
Site Search
Investors Home
News Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
SEC Filings
All Filings
Quarterly Results
Annual Reports & Proxies
Analyst Coverage
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
RSS Feeds
News Releases
Investors Home
News Releases
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
SEC Filings
All Filings
Quarterly Results
Annual Reports & Proxies
Analyst Coverage
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
RSS Feeds
Normal
Get News Alerts by RSS
(opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
12/12/2014
Puma Biotechnology Announces Positive Interim PB272 (Neratinib) Phase II Data at 2014 CTRC-AACR San Antonio Breast Cancer Symposium
Download
PDF format download (opens in new window)
12/02/2014
Puma Biotechnology Updates Timeline for Filing New Drug Application
Download
PDF format download (opens in new window)
11/13/2014
Puma Biotechnology Announces Positive Top Line Results from PB272 Phase II Trial in HER2 Positive Metastatic Breast Cancer (NEfERTT Trial)
Download
PDF format download (opens in new window)
11/12/2014
Puma Biotechnology to Present at Stifel 2014 Healthcare Conference
Download
PDF format download (opens in new window)
11/10/2014
Puma Biotechnology Reports Third Quarter 2014 Financial Results
Download
PDF format download (opens in new window)
09/29/2014
Puma Biotechnology Announces Positive Initial Results from PB272 Phase II Trial in HER2 Mutated Non-Small Cell Lung Cancer
Download
PDF format download (opens in new window)
09/03/2014
Puma Biotechnology Announces Late-Breaking Oral Presentation on Neratinib in NSCLC with HER2 Mutations at ESMO 2014
Download
PDF format download (opens in new window)
08/11/2014
Puma Biotechnology Reports Second Quarter 2014 Financial Results
Download
PDF format download (opens in new window)
07/22/2014
Puma Biotechnology Announces Positive Top Line Results from Phase III PB272 Trial in Adjuvant Breast Cancer (ExteNET Trial)
Download
PDF format download (opens in new window)
07/22/2014
Puma Biotechnology Announces Amendment to Neratinib Licensing Agreement with Pfizer
Download
PDF format download (opens in new window)
06/05/2014
Puma Biotechnology to Present at the Goldman Sachs 35th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
06/01/2014
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data at the 2014 ASCO Annual Meeting
Download
PDF format download (opens in new window)
05/29/2014
Puma Biotechnology to Present at Jefferies 2014 Global Healthcare Conference
Download
PDF format download (opens in new window)
05/15/2014
Puma Biotechnology to Present at UBS Global Healthcare Conference
Download
PDF format download (opens in new window)
05/14/2014
Puma Biotechnology Expands Cohort in Phase II Trial of PB272 (Neratinib) in HER2 Mutation-Positive Solid Tumor Patients
Download
PDF format download (opens in new window)
05/12/2014
Puma Biotechnology Reports First Quarter 2014 Financial Results
Download
PDF format download (opens in new window)
05/07/2014
Puma Biotechnology to Present at Bank of America Merrill Lynch 2014 Health Care Conference
Download
PDF format download (opens in new window)
04/07/2014
Puma Biotechnology Announces Presentation of Positive PB272 Phase II Data from I-SPY 2 TRIAL
Download
PDF format download (opens in new window)
03/12/2014
Puma Biotechnology to Present at Bank of America Merrill Lynch Smid Cap Conference
Download
PDF format download (opens in new window)
03/05/2014
Puma Biotechnology Announces Oral Presentation on I-SPY2 TRIAL at AACR Annual Meeting 2014
Download
PDF format download (opens in new window)
03/03/2014
Puma Biotechnology Reports Fourth Quarter and Full Year 2013 Financial Results
Download
PDF format download (opens in new window)
02/25/2014
Puma Biotechnology to Present at Cowen Health Care Conference
Download
PDF format download (opens in new window)
02/14/2014
Puma Biotechnology Closes $138 Million Public Offering of Common Stock
Download
PDF format download (opens in new window)
02/12/2014
Puma Biotechnology Announces Underwriters’ Full Exercise of Option to Purchase Additional Shares
Download
PDF format download (opens in new window)
02/11/2014
Puma Biotechnology Prices Public Offering of Common Stock
Download
PDF format download (opens in new window)
02/06/2014
Puma Biotechnology Announces Positive Outcome of European Opposition Proceedings
Download
PDF format download (opens in new window)